Obecabtagene autoleucel (obe-cel; Aucatzyl) has been approved by the FDA to treat patients with relapsed or refractory B-cell ...
Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent ...
Ascentage Pharma, a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback